Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation

Recruiting now · Phase 2

Conditions studied: Infusion Reactions

In brief

This study will evaluate the safety of infusion of the investigational cord blood units by carefully documenting all infusion-related problems.

Key facts

Study ID

NCT01656603

Run by

New York Blood Center

People needed

9999

Starts

2012-02-01

Expected to finish

2030-12-01

Last updated by the study team

2026-04-13

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis: Patients with disorders affecting the hematopoietic system that are inherited, acquired, or result from myeloablative treatment.
• Patients: Patients of any age and either gender
• Cord blood product manufactured by the NCBP (at least one, if the graft contains more than one units)

You may not qualify if…

• Patients who are receiving licensed cord blood products (only)
• Patients who are receiving unlicensed cord blood products from other banks (only)
• Patients who are transplanted at non-US transplant centers
• Patients who are receiving cord blood products that will be "manipulated" post-thaw (e.g., ex vivo expansion, incubation in vitro, etc.)

Where it is running

• National Institutes of Health — Bethesda, Maryland, United States (enrolling)
• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States (enrolling)
• James Graham Brown Cancer Center — Louisville, Kentucky, United States (enrolling)
• City of Hope — Duarte, California, United States (enrolling)
• Massachusetts General Hospital — Boston, Massachusetts, United States (enrolling)
• Children's of Alabama — Birmingham, Alabama, United States (enrolling)
• Indiana University — Indianapolis, Indiana, United States (enrolling)
• Rady Children's Hospital — San Diego, California, United States (enrolling)
• Stanford Health Care — Stanford, California, United States (enrolling)
• The Children's Hospital of Colorado — Aurora, Colorado, United States (enrolling)
• UCSD Moores Cancer Center — La Jolla, California, United States (enrolling)
• Presbyterian / St. Luke's Medical Center — Denver, Colorado, United States (enrolling)
• Alfred I. DuPont Hospital for Children — Wilmington, Delaware, United States (enrolling)
• Children's National Medical Center — Washington D.C., District of Columbia, United States (enrolling)
• Nemour's Children's Clinic and Hospital — Jacksonville, Florida, United States (enrolling)
• Phoenix Children's Hospital — Phoenix, Arizona, United States (enrolling)
• University of Miami/Jackson Memorial Hospital — Miami, Florida, United States (enrolling)
• Florida Hospital, Florida Center for Cellular Therapy — Orlando, Florida, United States (enrolling)
• All Children's Hospital, John Hopkins Medicine — St. Petersburg, Florida, United States (enrolling)
• Northside Hosptal — Atlanta, Georgia, United States (enrolling)
• Children's Healthcare of Atlanta — Atlanta, Georgia, United States (enrolling)
• Ann & Robert H. Lurie Children's Hospital of Chicago — Chicago, Illinois, United States (enrolling)
• Northwestern Memorial Hospital — Chicago, Illinois, United States (enrolling)
• University of Colorado Hospital — Aurora, Colorado, United States (enrolling)
• Dana Farber Cancer Instistute — Boston, Massachusetts, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.